A short acting psychedelic is in trials for postpartum depression. What the research shows, and what it does not.
Navigating new parenthood can bring profound joy, and, for some, unexpected despair. About 1 in 8 women in the United States report symptoms of postpartum depression, according to the Centers for Disease Control and Prevention, often during what everyone around them expects to be a radiant time. Research on RE104, a fast acting psychedelic compound, offers one glimpse of where treatment may be heading. Here is what is emerging, and what it does not yet mean.
The National Institute of Mental Health explains that postpartum depression goes beyond the baby blues. It is marked by persistent sadness, feelings of emptiness, changes in appetite or sleep, difficulty bonding with the baby, and in some cases, overwhelming anxiety or hopelessness. Unlike temporary mood shifts, postpartum depression can last for weeks or months without treatment and may affect a parent's ability to care for themselves or their child. It is treatable, and getting support early makes a meaningful difference.
RE104 is a psychedelic compound that researchers are studying as a potential therapy for mood disorders, including postpartum depression. It is related to psilocybin, the active ingredient found in certain mushrooms, but it has been developed to produce a shorter and more controlled experience. Where psilocybin can last six hours or more, RE104 is designed to produce its effect in roughly three. That shorter duration could make it more practical in a clinical setting, particularly for new parents who cannot easily commit to an all day session.
Scientists are interested in compounds like RE104 because of their potential to promote neuroplasticity, the brain's ability to form new connections and adapt. According to the American Psychological Association, research suggests that psychedelics may help people move out of rigid thought patterns that sustain depression. For someone experiencing postpartum depression, that could mean finding new ways of relating to themselves, their baby, and their circumstances. These treatments are not about escaping reality. They involve carefully guided sessions with clinical supervision.
RE104 and other psychedelic therapies are still under study and are not approved for general use. The Mayo Clinic and other leading institutions emphasize that psychedelic treatment belongs in safe, professional environments with trained providers. Using psychedelics outside of research or medical care carries real risks, particularly for people with underlying mental health conditions. The hope is that as trials progress, new options may become available under careful supervision.
In communities across Phoenix, Mesa, and Scottsdale, many families are navigating the challenges of new parenthood. Postpartum depression can feel isolating, and research like the RE104 trials shows that innovation in mental health care is continuing. These treatments are not available in everyday practice, but they represent a broader shift in how science approaches mood disorders.
For now, therapy, support groups, medication where appropriate, and other evidence based treatments remain the effective options for postpartum depression. At The Healing Effect, we follow these developments with interest while providing care to individuals and families in Mesa, Scottsdale, and Phoenix. If you or someone you love is struggling after the birth of a child, the support available now is worth exploring rather than waiting on what may come later.
If the calm on the outside is costing you a lot on the inside, our care team can help you find a therapist who fits, at your pace.
Reach OutNo. It is an investigational compound in clinical trials and is not approved for general use.
It is related, but designed to produce a shorter experience, roughly three hours rather than six or more, which may make it more practical in a clinical setting.
For their potential effect on neuroplasticity, the brain's capacity to form new connections, which may help interrupt the rigid thought patterns that sustain depression.
Therapy, peer and family support, and medication where a prescriber determines it is appropriate. These are the established options today.
When sadness, emptiness, anxiety, or difficulty bonding persist beyond the first couple of weeks. Earlier support generally means an easier recovery.
The Healing Effect is not a crisis service. If you are in crisis or thinking about harming yourself, call or text 988 to reach the Suicide and Crisis Lifeline, available 24 hours a day, 7 days a week.
Sources: the Centers for Disease Control and Prevention (prevalence of postpartum depression symptoms), the National Institute of Mental Health (postpartum depression), the American Psychological Association (psychedelics and rigid thought patterns), the Mayo Clinic (supervision and safety), and reported Phase 2 results for RE104.
Tell us a little about what is going on and our care team will help you find a therapist who fits, at your pace.
Reach Out